Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-01

FDA Approved: PHENYTEK — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for PHENYTEK (extended phenytoin sodium) from Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTEK (Phenytoin sodium; Extended phenytoin sodium)

Snippet

SUPPL AP for PHENYTEK (EXTENDED PHENYTOIN SODIUM)